A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs
Clinical trial NCT07343245 · RECRUITING
Trial details
- NCT number
- NCT07343245
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-02-22
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.